Sudarshan Pharma Industries consolidated net profit rises 44.80% in the March 2026 quarter

Sales rise 36.72% to Rs 220.92 crore

Net profit of Sudarshan Pharma Industries rose 44.80% to Rs 10.73 crore in the quarter ended March 2026 as against Rs 7.41 crore during the previous quarter ended March 2025. Sales rose 36.72% to Rs 220.92 crore in the quarter ended March 2026 as against Rs 161.59 crore during the previous quarter ended March 2025.

For the full year,net profit rose 55.64% to Rs 23.30 crore in the year ended March 2026 as against Rs 14.97 crore during the previous year ended March 2025. Sales rose 39.21% to Rs 703.06 crore in the year ended March 2026 as against Rs 505.04 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	220.92	161.59	37	703.06	505.04	39
OPM %	9.14	9.86	-	7.30	7.73	-
PBDT	16.80	12.37	36	34.33	25.64	34
PBT	15.70	11.54	36	30.54	22.84	34
NP	10.73	7.41	45	23.30	14.97	56

Powered by Capital Market - Live News